A recent joint study conducted by the FDA and Duke University found that 54% of clinical investigators only complete a single study. This alarmingly high turnover rate means that pharmaceutical, medical device, and contract research organizations (CROs) need to drastically improve their relationships with investigators and sites – now.

In this 30-minute on-demand webinar, Param Singh, director of clinical operations solutions, presents a practical approach to solving this common, yet serious, business problem. He discusses specific scenarios and demonstrates how to address them.